A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities behind the weight loss boom.
Continue Reading
Off-label GLP-1 use highlights the cultural pressures driving body anxieties
